APA

Bleecker E. R., FitzGerald J. M., Chanez P., Papi A., Weinstein S. F., Barker P., Sproule S., Gilmartin G., Aurivillius M., Werkström V. & Goldman M. (20170410). Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β. : Lancet (London, England).

Chicago

Bleecker Eugene R, FitzGerald J Mark, Chanez Pascal, Papi Alberto, Weinstein Steven F, Barker Peter, Sproule Stephanie, Gilmartin Geoffrey, Aurivillius Magnus, Werkström Viktoria and Goldman Mitchell. 20170410. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β. : Lancet (London, England).

Harvard

Bleecker E. R., FitzGerald J. M., Chanez P., Papi A., Weinstein S. F., Barker P., Sproule S., Gilmartin G., Aurivillius M., Werkström V. and Goldman M. (20170410). Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β. : Lancet (London, England).

MLA

Bleecker Eugene R, FitzGerald J Mark, Chanez Pascal, Papi Alberto, Weinstein Steven F, Barker Peter, Sproule Stephanie, Gilmartin Geoffrey, Aurivillius Magnus, Werkström Viktoria and Goldman Mitchell. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β. : Lancet (London, England). 20170410.